Comparative Assessment of VTE and Other Risks among Patients with Rheumatoid Arthritis treated with Baricitinib versus Tumor Necrosis Factor Inhibitors: A Multi-database Observational Cohort Study

ENCePP Code of conduct

No

Data sources

• Data source(s):
  THIN® (The Health Improvement Network®)

  Clinical Practice Research Datalink

  Sweden National Prescribed Drugs Register / Läkemedelsregistret

  German Pharmacoepidemiological Research Database
• Data source(s), other:
  Pharmetrics Plus United States, Humana United States, Aetna United States, Corrona RA Registry United States, Corrona RA Registry Japan
• Data sources (types):
  Administrative healthcare records (e.g., claims)

  Disease registry

  Drug dispensing/prescription data

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No